Carbiotix AB (publ) (NGM:CRBX)

Market Cap	25.87M
Revenue (ttm)	2.31M
Net Income (ttm)	-14.46M
Shares Out	4.98M
EPS (ttm)	-3.10
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	257
Average Volume	5,493
Open	6.20
Previous Close	4.82
Day's Range	5.90 - 6.50
52-Week Range	3.70 - 14.75
Beta	0.65
RSI	44.40
Earnings Date	Nov 11, 2025

About Carbiotix AB

Carbiotix AB (publ), a biotechnology company develops health testing and microbiome modulators to address a range of chronic and metabolic diseases. Its portfolio includes prebiotic ingredients and diagnostic testing services. The company develops CarbiAXOS, a second-generation prebiotic soluble fiber based on virgin and upcycled natural substrates containing arabinoxylo-oligosaccharides that is customized to meet customer needs to the production of short chain fatty acids or any other effect; and LinkGut, a health test. Carbiotix AB (publ) was...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2014
• Employees: 8
• Stock Exchange: Nordic Growth Market
• Ticker Symbol: CRBX

Financial Performance

In 2024, Carbiotix AB's revenue was 2.86 million, a decrease of -33.38% compared to the previous year's 4.29 million. Losses were -16.13 million, 19.7% more than in 2023.